Simplified Large-Scale Sanger Genome Sequencing for Influenza A/H3N2 Virus

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Lee, Hong Kai ^a,b   Tang, Julian Wei Tze ^c,d   Kong, Debra Han Lin ^b   Koay, Evelyn Siew Chuan ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPLICON; ARTICLE; GENE SEQUENCE; INFLUENZA VIRUS A H3N2; MDCK CELL; NONHUMAN; NOSE SMEAR; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SANGER SEQUENCING; THROAT CULTURE; VIRUS CULTURE; VIRUS GENOME;

GENOME, VIRAL; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

ORTHOMYXOVIRIDAE;

EID: 84878546446     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064785     Document Type: Article

References (40)

1. Baillie GJ, Galiano M, Agapow PM, Myers R, Chiam R, et al. (2012) Evolutionary dynamics of local pandemic H1N1/2009 influenza virus lineages revealed by whole-genome analysis. J Virol 86: 11-18.
2. Chen R, Holmes EC, (2008) The evolutionary dynamics of human influenza B virus. J Mol Evol 66: 655-663.
3. Fan X, Zhu H, Zhou B, Smith DK, Chen X, et al. (2012) Emergence and dissemination of a swine H3N2 reassortant influenza virus with 2009 pandemic H1N1 genes in pigs in China. J Virol 86: 2375-2378.
4. Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, et al. (2005) Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 437: 1162-1166.
5. Seyer R, Hrincius ER, Ritzel D, Abt M, Mellmann A, et al. (2012) Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice. J Infect Dis 205: 262-271.
6. Simonsen L, Viboud C, Grenfell BT, Dushoff J, Jennings L, et al. (2007) The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol 24: 1811-1820.
7. Narasaraju T, Sim MK, Ng HH, Phoon MC, Shanker N, et al. (2009) Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: insights into viral virulence, tissue tropism and host pathogenesis. Microbes Infect 11: 2-11.
8. Piralla A, Pariani E, Rovida F, Campanini G, Muzzi A, et al. (2011) Segregation of virulent influenza A(H1N1) variants in the lower respiratory tract of critically ill patients during the 2010-2011 seasonal epidemic. PLoS One 6: e28332.
9. Tsai KN, Chen GW, (2011) Influenza genome diversity and evolution. Microbes Infect 13: 479-488.
10. Chen GW, Yang CC, Tsao KC, Huang CG, Lee LA, et al. (2004) Influenza A virus PB1-F2 gene in recent Taiwanese isolates. Emerg Infect Dis 10: 630-636.
11. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, et al. (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature 437: 376-380.
12. Sanger F, Nicklen S, Coulson AR, (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74: 5463-5467.
13. Kircher M, Kelso J, (2010) High-throughput DNA sequencing-concepts and limitations. Bioessays 32: 524-536.
14. Loman NJ, Misra RV, Dallman TJ, Constantinidou C, Gharbia SE, et al. (2012) Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol 30: 434-439.
15. Luo C, Tsementzi D, Kyrpides N, Read T, Konstantinidis KT, (2012) Direct comparisons of Illumina vs. Roche 454 sequencing technologies on the same microbial community DNA sample. PLoS One 7: e30087.
16. Suzuki S, Ono N, Furusawa C, Ying BW, Yomo T, (2011) Comparison of sequence reads obtained from three next-generation sequencing platforms. PLoS One 6: e19534.
17. Archer J, Baillie G, Watson SJ, Kellam P, Rambaut A, et al. (2012) Analysis of high-depth sequence data for studying viral diversity: a comparison of next generation sequencing platforms using Segminator II. BMC bioinformatics 13: 47.
18. Barzon L, Lavezzo E, Militello V, Toppo S, Palu G, (2011) Applications of next-generation sequencing technologies to diagnostic virology. Int J Mol Sci 12: 7861-7884.
19. Bell J, (2008) A simple way to treat PCR products prior to sequencing using ExoSAP-IT. BioTechniques 44: 834.
20. Dugan KA, Lawrence HS, Hares DR, Fisher CL, Budowle B, (2002) An improved method for post-PCR purification for mtDNA sequence analysis. J Forensic Sci 47: 811-818.
21. Chan CH, Lin KL, Chan Y, Wang YL, Chi YT, et al. (2006) Amplification of the entire genome of influenza A virus H1N1 and H3N2 subtypes by reverse-transcription polymerase chain reaction. J Virol Methods 136: 38-43.
22. Djikeng A, Halpin R, Kuzmickas R, Depasse J, Feldblyum J, et al. (2008) Viral genome sequencing by random priming methods. BMC Genomics 9: 5.
23. Roy T, Agrawal AS, Mukherjee A, Mishra AC, Chadha MS, et al. (2011) Surveillance and molecular characterization of human influenza B viruses during 2006-2010 revealed co-circulation of Yamagata-like and Victoria-like strains in eastern India. Infect Genet Evol 11: 1595-1601.
24. Lee HK, Loh TP, Lee CK, Tang JW, Chiu L, et al. (2012) A universal influenza A and B duplex real-time RT-PCR assay. J Med Virol 84: 1646-1651.
25. Krafft AE, Russell KL, Hawksworth AW, McCall S, Irvine M, et al. (2005) Evaluation of PCR testing of ethanol-fixed nasal swab specimens as an augmented surveillance strategy for influenza virus and adenovirus identification. J Clin Microbiol 43: 1768-1775.
26. Lee HK, Lee CK, Loh TP, Tang JW, Chiu L, et al. (2010) Diagnostic testing for pandemic influenza in Singapore: a novel dual-gene quantitative real-time RT-PCR for the detection of influenza A/H1N1/2009. J Mol Diagn 12: 636-643.
27. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M, et al. (2009) Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol 83: 10309-10313.
28. Ewing B, Green P, (1998) Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8: 186-194.
29. Salzberg SL, Church D, DiCuccio M, Yaschenko E, Ostell J, (2004) The genome Assembly Archive: a new public resource. PLoS Biol 2: E285.
30. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, et al. (2012) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 40: D13-25.
31. Alvarez AC, Brunck ME, Boyd V, Lai R, Virtue E, et al. (2008) A broad spectrum, one-step reverse-transcription PCR amplification of the neuraminidase gene from multiple subtypes of influenza A virus. Virol J 5: 77.
32. Choi JS, Kim JS, Joe CO, Kim S, Ha KS, et al. (1999) Improved cycle sequencing of GC-rich DNA template. Exp Mol Med 31: 20-24.
33. Bush RM, Smith CB, Cox NJ, Fitch WM, (2000) Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution. Proc Natl Acad Sci U S A 97: 6974-6980.
34. Deom CM, Caton AJ, Schulze IT, (1986) Host cell-mediated selection of a mutant influenza A virus that has lost a complex oligosaccharide from the tip of the hemagglutinin. Proc Natl Acad Sci U S A 83: 3771-3775.
35. Palese P, Wang TT (2011) Why do influenza virus subtypes die out? A hypothesis. MBio 2.
36. Pica N, Hai R, Krammer F, Wang TT, Maamary J, et al. (2012) Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A 109: 2573-2578.
37. WHO (2007) Recommended composition of influenza virus vaccines for use in the 2008 influenza season. Wkly Epidemiol Rec 82: 351-356.
38. WHO (2009) Recommended composition of influenza virus vaccines for use in the 2010 influenza season (southern hemisphere winter). Wkly Epidemiol Rec 84: 421-431.
39. WHO (2012) Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season. Wkly Epidemiol Rec 87: 83-95.
40. McHardy AC, Adams B, (2009) The role of genomics in tracking the evolution of influenza A virus. PLoS Pathog 5: e1000566.